|PROVAXS – Ghent University||Business Development Manager||Belgium|
Which promises to be delivered by high potential vaccines?
As Business Developer Dr. Sven Arnouts coordinates technology transfer for PROVAXS at Ghent University in Belgium.
He facilitates interaction and collaboration between industry and Ghent University’s experts in infectious diseases and immunity in animal health. In 2019 he started the One Health Platform at Ghent University.
Dr. Arnouts graduated in 1990 as Bio-engineer in animal breeding and cell and gene technology. In 1994 he obtained his PhD in avian growth physiology and immunology at the University of Leuven on an industrial project in collaboration with Solvay-Duphar. From 1994 to 2006 he was global R&D Manager Agriculture at INVE where he was responsible for research activities in animal nutrition for pigs, poultry and ruminants with a special focus on the relation between nutrition and health.
• is Chairman of the Board of Directors of Flanders Vaccine since January 2016
• represents Belgium in the Executive Committee of the International
Research Consortium STAR-IDAZ IRC